A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML-Reference-Cited by-同舟云学术

A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML

Published:2021-12 Issue: Volume:111 Page:106737
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Webster Jonathan A.,Robinson Tara M.^ORCID,Blackford Amanda L.^ORCID,Warlick Erica,Ferguson Anna,Borrello Ivan,Zahurak Marianna^ORCID,Jones Richard J.,Smith B. Douglas^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference40 articles.

1. Minute chromosome in human chronic granulocytic leukemia;Nowell;Science,1960

2. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the philadelphia chromosome;Stam;N. Engl. J. Med.,1985

3. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining;Rowley;Nature,1973

4. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N. Engl. J. Med.,2001

5. Cancer statistics, 2014;Siegel;CA Cancer J. Clin.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Treatment of Chronic Myeloid Leukemia;Recent Patents on Anti-Cancer Drug Discovery;2024-02

2. Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study;British Journal of Haematology;2023-09-11

3. The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities;Current Hematologic Malignancy Reports;2023-02-13

4. Anti-CD19 chimeric antigen receptor T-cell followed by interferon−α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report;Frontiers in Oncology;2022-11-24